Company: SONM
Filing Date: 2025-10-09
Form Type: S-1/A
Source: 0001493152-25-017589
Chunk: 48

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-10-09
Form: S-1/A
Chunk 48
---
business day following the Signing Date, we will file a registration statement covering the Purchase Shares, and have such registration statement declared effective as promptly as practicable but no later than the earlier of (x) the 90 thcalendar day following the filing thereof if the SEC notifies us that it will “review” such registration statement and (y) the 10 thcalendar day after the date we are notified by the SEC that such registration statement will not be “reviewed” or will not be subject to further review.

Trading Symbol and Market

Our common stock is traded on Nasdaq under the symbol “SONM.”

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Equiniti Trust Company, LLC (formerly, American Stock Transfer & Trust Company, LLC). The transfer agent’s address is 6201 15th Avenue, Brooklyn, New York 11219, telephone (800) 937-5449.

| 30 |

<div align='center'>PLAN OF DISTRIBUTION

(CONFLICTS OF INTEREST)</div>

We are registering the resale by Chardan of up to 350,000,000 shares of our Common Stock. The actual number of shares of our Common Stock issuable will vary depending on the then current market price of shares of our Common Stock sold to Chardan in this offering.

We will not receive any of the proceeds from the sale of the securities by Chardan. However, we may receive up to $500.0 million in aggregate gross proceeds from Chardan under the Purchase Agreement in connection with sales of shares of our Common Stock to Chardan pursuant to the Purchase Agreement after the date of this prospectus. The aggregate proceeds to Chardan will be the purchase price of the securities less any discounts and commissions borne by Chardan.

Once issued and upon effectiveness of the registration statement of which this prospectus forms a part, the securities beneficially owned by Chardan covered by this prospectus may be offered and sold from time to time by Chardan, including any donees, pledgees, transferees or other successors in interest selling securities received after the date of this prospectus from Chardan as a gift, pledge, partnership distribution or other transfer. Chardan will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may be made on one or more exchanges or in the over-the-counter market or otherwise, at prices and under terms then prevailing or at prices related to the